NewKerala.com

Key Points

India's bioeconomy has experienced phenomenal growth, skyrocketing from just $10 billion to $165.7 billion over the past decade. The country has become a global vaccine manufacturing powerhouse with Serum Institute capturing 24% of the world market. India achieved 20% ethanol blending in petrol five years ahead of schedule, saving massive foreign exchange and boosting farmer incomes. The new BioE3 Policy aims to further accelerate this growth through sustainable biomanufacturing practices targeting $300 billion by 2030.

Key Points: India's Bioeconomy Grows from $10 Billion to $165.7 Billion in 10 Years

  • Bioeconomy expanded from $10B to $165.7B between 2014-2024
  • Serum Institute now holds 24% of global vaccine market share
  • Achieved 20% ethanol blending five years ahead of schedule
  • New BioE3 Policy promotes sustainable biomanufacturing and green growth
3 min read

India's bioeconomy leaps from just $10 bn to $165.7 bn in 10 years

India's bioeconomy surges 16x to $165.7B, driven by biotech innovation, vaccine manufacturing dominance, and achieving 20% ethanol blending five years ahead of target.

"India has emerged as one of the fastest-growing bioeconomies in the world - Official Report"

New Delhi, Sep 5

Over the past decade, India has emerged as one of the fastest-growing bioeconomies in the world, with the sector expanding to $165.7 billion in 2024 from just $10 billion in 2014. With an ambitious target of $300 billion by 2030, the bioeconomy is steadily becoming a cornerstone of India’s sustainable growth and innovation, driven by advancements in biotechnology, agricultural innovation, biomanufacturing, and healthcare.

The four key subsectors of the country’s bioeconomy comprise BioIndustrial (47 per cent), BioPharma (35 per cent), BioAgri (8 per cent), and BioResearch (9 per cent), according to official figures.

Significant biotech milestones achieved by India in 2025 include consolidating its position as a top vaccine manufacturer. According to the WHO Global Vaccine Market Report, the Serum Institute of India’s share of the global vaccine market, excluding Covid-19 vaccines, rose from 19 per cent in 2021 to 24 per cent in 2024. This was driven by higher production of pneumococcal conjugate vaccine (PCV), measles-rubella (MR), and tetanus-diphtheria (Td) vaccines.

The global vaccine market is highly concentrated, with 10 manufacturers supplying over 80 per cent of vaccines. Three of these - Serum Institute, Bharat Biotech, and Biological E - are from India. Indian firms supplied 40 per cent of the WHO’s vaccine purchases, with a large share used domestically. About 20 per cent of India’s vaccine exports went to the WHO African Region.

India has also achieved 20 per cent ethanol blending (E20) in petrol in 2025, five years ahead of the original target. This is a steep rise from 1.5 per cent in 2014 and reflects the country’s progress towards building a sustainable bio-economy. The programme has delivered multiple bio-economy benefits, including higher incomes for farmers who, between Ethanol Supply Year (ESY) 2014–15 and June 2025, received Rs 1,21,000 crore for ethanol feedstock, eliminating sugarcane arrears and improving the viability of maize cultivation.

At 20 per cent blending, it is expected that payment to the farmers in this year alone will be to the tune of Rs 40,000 crore and forex savings will be around Rs 43,000 crore.

Till July 2025, ethanol blending substituted 245 lakh metric tonnes of crude oil and conserved Rs 1,44,087 crore in foreign exchange, significantly strengthening energy security.

This achievement underscores the role of ethanol blending in integrating energy, agriculture and sustainability, thereby contributing to India’s bio-economy.

The Union Cabinet approved the proposal of the Department of Biotechnology (DBT) on August 24, 2024, for India’s first biotechnology policy, the BioE3 Policy (Biotechnology for Economy, Environment and Employment). The policy focuses on fostering high-performance biomanufacturing and lays down the framework for the Biomanufacturing and Biofoundry Initiative. This initiative aims to promote green growth by shifting from consumptive manufacturing to regenerative and sustainable practices.

The bioeconomy has strong potential to mitigate climate change by reducing greenhouse gas emissions and promoting sustainable practices. It supports cleaner farming methods, carbon storage in agriculture, balanced diets, and forest restoration. At the same time, it encourages recycling, reduces food waste, bioenergy use, and greener industrial processes. By combining these approaches, the bioeconomy helps lower emissions while advancing sustainability and resource efficiency.

- IANS

Share this article:

Reader Comments

P
Priya S
So proud of our vaccine manufacturers! Serum Institute, Bharat Biotech, and Biological E making India the pharmacy of the world. 40% of WHO's vaccine purchases coming from India is just amazing! 💉
R
Rohit P
The farmer income boost through ethanol program is the real win here. Rs 1,21,000 crore to farmers and eliminating sugarcane arrears - this is development that reaches the grassroots level.
M
Michael C
As someone working in sustainable tech, India's bioeconomy growth is impressive but I hope the environmental impact assessments are rigorous. Rapid expansion needs careful monitoring to ensure it's truly sustainable.
S
Shreya B
The BioE3 Policy looks promising! Biotechnology for Economy, Environment and Employment - exactly what India needs. Hope this creates more job opportunities for biology graduates across the country. 🧬
V
Vikram M
Rs 43,000 crore forex savings from ethanol blending alone! This is strategic economic planning at its best. Reducing oil imports while supporting agriculture - win-win for the nation.
N
Nisha Z
While the numbers are impressive, I hope the benefits are distributed evenly across states. Sometimes development is concentrated in certain regions. More transparency in regional distribution would be helpful.

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50